COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,304 Articles (22,772 medRxiv, 8,532 bioRxiv)

Most recent first Previous |  Page 158: Articles 1571-1580  | Next

Synthesis and Evaluation of Carmofur Analogs as Antiproliferative Agents, Inhibitors to the Main Protease (Mpro) of SARS-CoV-2, and Membrane Rupture-Inducing Agents
Gu, T., Lu, A., Wang, X., Brahan, N., Xu, L., Zhang, L., Su, K., Seow, K., Vu, J., Luk, C., Lee, Y., Raman, A., Pazzi, J., Njoo, E.
10.1101/2024.10.11.617727 — Posted: 2024-10-14
Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium.
Dirvin, B. G., Noh, H., Tomassoni, L., Cao, D., Zhou, Y., Ke, X., Qian, J., Schotsaert, M., Garcia-Sastre, A., Karan, C., Califano, A., Cardoso, W. V.
10.1101/2024.10.11.617898 — Posted: 2024-10-14
Integrative multi-ethnic Mendelian randomisation identifies tissue-specific causal genes for Coronary Artery Disease and interactions with post-acute Covid.
Jaros, R., O'Sullivan, J. M.
10.1101/2024.10.11.24315315 — Posted: 2024-10-13
Pre-pandemic national immunisation programme strength and health workforce capacity improved routine immunisation resilience during the COVID-19 pandemic
Evans, B., Kaiser, L., Keiser, O., Jombart, T.
10.1101/2024.10.09.24315115 — Posted: 2024-10-11
Performance of and preference for saliva sampling for detection of SARS-COV-2 in the Bahamas
Martin, I., McMillan, P.
10.1101/2024.10.10.24314969 — Posted: 2024-10-11
Association of COVID-19 risk factors with systemic fungal infections in hospitalized patients
Wilbourn, A. C., Tsodikov, O. V., Garneau-Tsodikova, S.
10.1101/2024.10.10.24315254 — Posted: 2024-10-11
Estimating the generation time for SARS-CoV-2 transmission using household data in the United States, December 2021 - May 2023
Chan, L. Y. H., Morris, S. E., Stockwell, M. S., Bowman, N. M., Asturias, E., Rao, S., Lutrick, K., Ellingson, K. D., Nguyen, H. Q., Maldonado, Y., McLaren, S. H., Sano, E., Biddle, J. E., Smith-Jeffcoat, S. E., Biggerstaff, M., Rolfes, M. A., Talbot, H. K., Grijalva, C. G., Borchering, R. K., Mellis, A. M., RVTN-Sentinel Study Group
10.1101/2024.10.10.24315246 — Posted: 2024-10-11
Longitudinal monitoring of respiratory syncytial virus, SARS-CoV-2 and influenza in wastewater of a Southern Indian city
Venkatesh, A. M., S, S. R., Movva, P., Madhukar, M. K., Panda, A., Venkata Mohan, S., Mishra, R. K., Moharir, S. C.
10.1101/2024.10.11.24315282 — Posted: 2024-10-11
The impact of non-pharmaceutical interventions on early-stage COVID-19 epidemic dynamics in rural communities in the United States
Alahakoon, P., Taylor, P. G., McCaw, J.
10.1101/2024.10.11.24315297 — Posted: 2024-10-11
Intranasal delivery of a broadly neutralizing single domain antibody targeting ACE2 protects against SARS-CoV-2 infection
Blachier, S., Fernandez, I., Conquet, L., Giraud, E., Staropoli, I., Michel, V., Szilagyi, F., Guez, S., Boucharlat, A., Chiaravalli, J., Tran-Rajau, J., Dufour, E., Petres, S., Planas, D., Montagutelli, X., Agou, F., Rey, F. A., Lafaye, P., Enninga, J., Ayme, G., Schwartz, O., Brelot, A.
10.1101/2024.10.11.617877 — Posted: 2024-10-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).